Leading Stem Cell Expert: Stem Cells 101 - The Future of Medicine w/ Robert Hariri | EP #147
The conversation covers the current state of stem cell regulation, the basics of stem cells, their potential in regenerative medicine, and the future outlook for these therapies in the U.S. The conversation discusses the natural repair process involving stem cells and their diminishing supply with age, as well as the use of Viome's technology for personalized health guidance. The conversation delves into the decline of stem cell capacity with age, the potential of placental stem cells for supplementation, the establishment of stem cell banking, and the future of cellular engineering. The podcast discusses the importance of early disease detection through advanced diagnostic centers, the benefits of using placental cells for stem cell therapy, and the ethical concerns surrounding embryonic stem cells. The podcast discusses the use of placental stem cells, the controversy around embryonic
Viome uses technology from Los Alamos National Labs to provide personalized health guidance based on microbiome and RNA analysis, with positive user results.
Discussion on the potential of stem cells for cellular engineering and disease prevention.mention of a Skunk Works experiment that extended the lifespan of rats by 40% using stored stem cells.
“so people who've heard this conversation on these podcasts with me about longevity know that we are in Peak condition typically in our late 20s like 27 to 30 years old and it's a slow decline of loss of muscle a loss of immune function a loss of hormonal balance and very significantly a loss of stem cell capacity um and you can accept that and accept your fate or you can fight against it and I think one of the things”
Your call:
openRobert Hariri: We may be able to prevent and interrupt disease progress with the raw material supply of stem cells.
“I do believe there's room here and and I'm in the dialogue there's room to be more receptive and open to accelerating the process of review for cell therapies.”
Your call:
openHariri: Regulators can be more permissive and receptive to development models with a longer lens on patient results.
“Regulators can be more permissive allow for realworld evaluation of the long-term benefits of cell therapy in products that meet a high quality standard and that have the fundamental Assurance of safety acute safety that is necessary to get into the clinic if we did that we could build the database”
Your call:
openUnknown: Proactive healthcare approaches can prevent the tremendous cost of care by identifying and treating conditions pre-clinically.